Results: RTX quantifications using ELISA and miRAMM were highly correlated, but miRAMM measured consistently higher serum levels, suggesting its ability to detect total serum RTX (including free and complexed rituximab). RTX PK was highly variable between patients, with W2 levels ranging between 43 and 259 μg/mL and AUC ranging between 2,668 and 17,513 μg/mL by miRAMM. W2 RTX levels and AUC were significantly lower in males and in newly-diagnosed patients, and were negatively correlated with body surface area, baseline B-cell count, and BVAS/WG. In multivariate analyses, the main determinants of RTX PK were sex and new diagnosis. Patients with a new diagnosis had higher baseline B-cell counts and BVAS/WG. Patients reaching complete remission at month 6 had similar mean RTX levels compared to patients who did not reach complete remission (W2 level by miRAMM: 136±44 vs 139±46, p=0.76; AUC: 8420±2875 vs 8558±3452, p=0.85). Patients with higher RTX levels generally experienced longer B-cell depletion durations, but RTX levels at the different time-points and AUC were not associated with time to any relapse or time to severe relapse. Similar results were observed when using rituximab quantification by miRAMM and by ELISA. Conclusions: Despite a dosing protocol adjusted for body surface area, rituximab PK is highly variable between patients, its main determinants being sex and newly diagnosed disease. We did not observe an association between rituximab PK and clinical outcomes. Background: ANCA-associated vasculitis (AAVs), including granulomatosis with polyangiitis and microscopic polyangiitis, are small vessel vasculitides. Modern treatments have greatly improved survival in AAV patients, but significant longterm morbidity and mortality such as cardiovascular disease (CVD) are still associated with this disease. Objectives: The aim of our study was to assess the incidence, mortality and predictors of CVD in patients with AAVs Methods: We conducted a retrospective study of AAV diagnosed in Toulouse France teaching hospital between 1981 and 2015. Patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) were included and classified, after thorough medical chart review, according to the criteria proposed by the Chapel Hill Consensus Conference. Eosinophilic granulomatosis with polyangiitis were excuded. A survival analysis was performed. Hazard ratios and the comparative morbidity and mortality figure (CMF) was calculated as the ratio of expected number of deaths in the standard population to those observed as well as predictors of CVD in patients with AAV were also assessed. Results: We identified 361 subjects, only 125 met the inclusion criteria, 99 GPA and 26 MPA, 65 (42%) were men and mean age was 61.3±15.7 years at CVD occurrence with a mean follow-up of 88.4±78.3 months since diagnosis.Coronary artery disease (CAD) developed in 10 patients, and ischemic stroke developed in 9 patients (incidence rates of 8.5 per 1,000 person-years and 10.2 per 1,000 person-years, respectively). CAD incidence for AAV patients is two times more than in the general population, independent of age differences between the two populations using the Midi-Pyrénées county CAD registry as a reference (CMF of 1.96; 95CI 0.88 to 4.36). Ischemic stroke incidence for AAV patients is three times more than in the general population, independent of age differences between the two populations (CMF of 3.36; 95CI 1.75 to 6.46). Smoking habits and history of CAD at AAV diagnosis was strongly associated with CAD occurrence (adjusted HR 8.8; 95CI 2.12 to 36.56, p=0.003 and adjusted HR 10.3; 95CI 1.02 to 104.5, p=0.003, respectively). An ENT flare (adjusted HR 0.12) was a independent protective factor for CAD occurrence. We did not find any statistically significant associated factor with ischemic stroke occurrence in our cohort. Using direct standardisation, the age adjusted mortality rate for the AAV cohort was 22.5 per 1,000 person-years and for the general population 10.2 per 1,000 person-years. This indicates that mortality for AAV patients is one and a half times more than in the general population, independent of age differences between the two populations (CMF of 1.56; 95CI 1.02 to 2.39). Background: Adult-onset Still's disease (AOSD) and Behçet's disease (BD) are both systemic inflammatory diseases, the causes of which are largely unknown. They have been recently classified as autoinflammatory diseases, a group of diseases in which innate rather than acquired immunity plays important roles in their pathogenesis. As AOSD and BD are clinically distinct diseases, their cytokine networks should also be different. Objectives: In this study, we attempted to quantify the levels of multiple cytokines in the serum of patients by utilizing a beads-array technique and ELISA, and then compared the serum cytokine profiles of the two diseases by factor analysis. We then sought to clarify the hierarchical relationship between interleukin (IL-) 17A and interferon (IFN-) α using peripheral blood mononuclear cells (PBMCs). Methods: We quantified the serum levels of 10 cytokines (IFN-α, IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-10, IL-12p70, IL-17A and tumor necrosis factor α) in 16 AOSD patients and 28 BD patients using multiplex bead array assays and IL-18 along with ELISA. The data were then subjected to factor analysis. We next stimulated PBMCs from three healthy volunteers in vitro with class A CpG oligodeoxynucleotides (ODNs) in the presence or absence of IL-17A for 15 hours. We performed flowcytometric analysis to examine the expression of intracellular IFN-α in plasmacytoid dendritic cells (pDCs). Results: Two factors were extracted from the factor analysis using the data on 8 cytokines that were detectable in the serum of the patients. IL-17A and IFN-α, the levels of which showed a strong positive correlation in the serum of BD patients (Fig. A) , were the main components of Factor 1, while Factor 2 consisted of IL-6, IL-10 and IL-18 (Fig. B) . Patients were also plotted on a plane determined by Factors 1 and 2 according to each patient's factor scores. Those who were high in Factor 1 but low in Factor 2 were likely to be BD patients and vice versa, many of those who were high in Factor 2 but low in Factor 1 were AOSD patients. In terms of flowcytometric analysis, IL-17A alone did not induce IFN-α expression in pDCs, but it did substantially increase IFN-α-positive pDCs induced by CpG ODNs.
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Conclusions:
The cytokines examined were clearly separated into distinct groups by the factor analysis. Similarly, the AOSD and BD patients could be separated, although roughly. High levels of serum IL-6, -10 and -18 suggest AOSD while high levels of IFN-α and IL-17A indicate BD. To establish patterns of correlation among cytokines, it is important to focus on the cytokine concentrations in each patient, rather than the average cytokine concentrations in each of the diseases. In terms of the hierarchical relationship between IFN-α and IL-17A, a previous report suggested that IFN-α blocks IL-17A production in PBMCs from BD patients. Thus, we examined the effect of IL-17A on IFN-α production. It should be noted that the real stimulus for IFN-α release in BD is unknown. In addition, cells other than pDCs may be involved in the production of IFN-α. Nevertheless, understanding the hierarchical relationship among cytokines should prove to be helpful in clarifying the pathogenesis of various inflammatory diseases. 
